TY - JOUR
T1 - Lipid based formulations as supersaturating oral delivery systems
T2 - From current to future industrial applications
AU - Holm, René
AU - Kuentz, Martin
AU - Ilie-Spiridon, Alexandra Roxana
AU - Griffin, Brendan T.
N1 - Publisher Copyright:
© 2023 The Author(s)
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Lipid-based formulations, in particular supersaturated lipid-based formulations, are important delivery approaches when formulating challenging compounds, as especially low water-soluble compounds profit from delivery in a pre-dissolved state. In this article, the classification of lipid-based formulation is described, followed by a detailed discussion of different supersaturated lipid-based formulations and the recent advances reported in the literature. The supersaturated lipid-based formulations discussed include both the in situ forming supersaturated systems as well as the thermally induced supersaturated lipid-based formulations. The in situ forming drug supersaturation by lipid-based formulations has been widely employed and numerous clinically available products are on the market. There are some scientific gaps in the field, but in general there is a good understanding of the mechanisms driving the success of these systems. For thermally induced supersaturation, the technology is not yet fully understood and developed, hence more research is required in this field to explore the formulations beyond preclinical studies and initial clinical trials.
AB - Lipid-based formulations, in particular supersaturated lipid-based formulations, are important delivery approaches when formulating challenging compounds, as especially low water-soluble compounds profit from delivery in a pre-dissolved state. In this article, the classification of lipid-based formulation is described, followed by a detailed discussion of different supersaturated lipid-based formulations and the recent advances reported in the literature. The supersaturated lipid-based formulations discussed include both the in situ forming supersaturated systems as well as the thermally induced supersaturated lipid-based formulations. The in situ forming drug supersaturation by lipid-based formulations has been widely employed and numerous clinically available products are on the market. There are some scientific gaps in the field, but in general there is a good understanding of the mechanisms driving the success of these systems. For thermally induced supersaturation, the technology is not yet fully understood and developed, hence more research is required in this field to explore the formulations beyond preclinical studies and initial clinical trials.
KW - Lipid-based formulations
KW - Precipitation inhibitor, SMEDDS, SNEDDS.
KW - Supersaturated formulations
KW - Surfactants
UR - https://www.scopus.com/pages/publications/85168001634
U2 - 10.1016/j.ejps.2023.106556
DO - 10.1016/j.ejps.2023.106556
M3 - Article
C2 - 37543063
AN - SCOPUS:85168001634
SN - 0928-0987
VL - 189
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
M1 - 106556
ER -